Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Aprea Therapeutics, Inc. APRE

Full chart Compare
Set alert

Price alert · APRE

All alert types
0.51 USD -0.01 (-1.90%)

At closeNov 4, 2026, 4:00 PM EST

0.52 +0.02 +3.38%

After hours · Nov 4, 4:00 PM ET

0.5051 Day range 0.5319
0.41 52-week range 1.49
YTD
-40.77%
1 year
-63.12%

Financial health

Altman Z-Score

-11.80 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 4

Valuation

P/E -0.4×
FY 2017: -19.0×FY 2018: -18.6×FY 2019: -34.9×FY 2020: -1.9×FY 2021: -1.6×FY 2022: -0.0×FY 2023: -1.2×FY 2024: -1.4×FY 2025: -0.4×
FY 2017 5y median -1.2× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 29.2×FY 2024: 12.1×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 0.4×
FY 2017: -8.1×FY 2018: -5.6×FY 2019: 7.4×FY 2020: 1.3×FY 2021: 1.2×FY 2022: 0.0×FY 2023: 0.9×FY 2024: 0.9×FY 2025: 0.4×
FY 2017 5y median 0.9× FY 2025
P/FCF -0.4×
FY 2017: -20.6×FY 2018: -18.9×FY 2019: -34.5×FY 2020: -2.5×FY 2021: -1.6×FY 2022: -0.0×FY 2023: -1.4×FY 2024: -1.3×FY 2025: -0.4×
FY 2017 5y median -1.3× FY 2025
EV/EBITDA 0.7×
FY 2017: -17.4×FY 2018: -14.4×FY 2019: -28.4×FY 2020: -0.3×FY 2021: -0.2×FY 2022: 0.8×FY 2023: 0.3×FY 2024: 0.4×FY 2025: 0.7×
FY 2017 5y median 0.4× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -7.9×FY 2024: -3.1×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -231.2%
FY 2017: -4.9%FY 2018: -5.3%FY 2019: -2.9%FY 2020: -40.2%FY 2021: -61.7%FY 2022: -4560.1%FY 2023: -72.2%FY 2024: -74.9%FY 2025: -231.2%
FY 2017 5y median -74.9% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 98.8%FY 2024: -523.2%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -2652.8%FY 2024: -953.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -2449.6%FY 2024: -862.4%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -101.3%
FY 2017: 42.5%FY 2018: 30.2%FY 2019: -22.6%FY 2020: -69.7%FY 2021: -73.8%FY 2022: -439.3%FY 2023: -78.2%FY 2024: -67.1%FY 2025: -101.3%
FY 2017 5y median -78.2% FY 2025
ROIC -100.5%
FY 2017: -77.5%FY 2018: -27.0%FY 2019: -23.7%FY 2020: -67.9%FY 2021: -75.3%FY 2022: -420.7%FY 2023: -84.7%FY 2024: -69.5%FY 2025: -100.5%
FY 2017 5y median -84.7% FY 2025
ROA -79.1%
FY 2017: -61.3%FY 2018: -23.5%FY 2019: -21.0%FY 2020: -58.1%FY 2021: -64.3%FY 2022: -373.6%FY 2023: -63.1%FY 2024: -54.0%FY 2025: -79.1%
FY 2017 5y median -64.3% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 157.6%FY 2025: -100.0%
FY 2017 FY 2025
Operating Income 7.6%
FY 2017: 0.0%FY 2018: -4.0%FY 2019: -79.2%FY 2020: -78.8%FY 2021: 29.1%FY 2022: -202.8%FY 2023: 86.4%FY 2024: 7.4%FY 2025: 7.6%
FY 2017 FY 2025
EPS (diluted) 17.9%
FY 2017: 0.0%FY 2018: -2.2%FY 2019: -19.1%FY 2020: -92.6%FY 2021: 31.1%FY 2022: -3798.5%FY 2023: 99.7%FY 2024: 40.5%FY 2025: 17.9%
FY 2017 FY 2025
Free Cash Flow 5.0%
FY 2017: 0.0%FY 2018: -8.9%FY 2019: -75.3%FY 2020: -56.4%FY 2021: 9.9%FY 2022: 33.6%FY 2023: 50.9%FY 2024: -10.6%FY 2025: 5.0%
FY 2017 FY 2025

Financial Health

Current Ratio 5.6×
FY 2017: 5.8×FY 2018: 13.6×FY 2019: 14.7×FY 2020: 6.0×FY 2021: 7.7×FY 2022: 9.4×FY 2023: 5.1×FY 2024: 7.0×FY 2025: 5.6×
FY 2017 5y median 7.0× FY 2025
Quick Ratio 5.6×
FY 2017: 5.8×FY 2018: 13.6×FY 2019: 14.7×FY 2020: 6.0×FY 2021: 7.7×FY 2022: 9.4×FY 2023: 5.1×FY 2024: 7.0×FY 2025: 5.6×
FY 2017 5y median 7.0× FY 2025
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 1.2×
FY 2017: 1.6×FY 2018: 4.2×FY 2019: 4.6×FY 2020: 1.7×FY 2021: 1.4×FY 2022: 0.8×FY 2023: 1.5×FY 2024: 1.8×FY 2025: 1.2×
FY 2017 5y median 1.4× FY 2025
Interest Coverage 0.0×
FY 2017: -1056825×FY 2018: -90601×FY 2019: -189×FY 2020: -237×FY 2021: 0.0×FY 2022: -253×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31